Catalyst Wire Dossier Catalyst Wire Dossier

Intrastromal Transform Corneal Allograft (TCA)

· Allotex, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Intrastromal Transform Corneal Allograft (TCA), covering 2024-12-19 to 2024-12-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of an Intrastromal Transform Corneal Allograft (TCA) for Presbyopia Correction - Long Term Follow-up

See pricing